Stephen J. Immelt

Stephen J. Immelt

Senior Counsel
Washington, D.C.

Email [email protected]​

Phone +1 202 637 3660

Fax +1 202 637 5910

Practice groupLitigation, Arbitration, and Employment

"A very bright guy and a creative and analytical thinker."

Chambers USA 2014

Steve Immelt was Chief Executive Officer (CEO) of Hogan Lovells from 2014-2020 and was responsible for developing and driving our vision as a "bold and distinctive law firm creating valuable solutions for clients."

Steve has spent his time focused on achieving the firm's strategy and supporting partners in building their relationships with clients and each other around the world. He has introduced into Hogan Lovells a major global initiative known as "Project Redefine," which seeks to improve the way we do things for the benefit of our clients in a rapidly changing and evolving market.

He is also passionate about leadership behavior, taking the view that everyone at Hogan Lovells should be clear about what is expected of them, whether partners, associates, or members of the business services teams.

Before taking up the role of CEO in 2014, Steve was the global co-head of our Litigation and Arbitration practice and a long-standing member of our International Management Committee. He has decades of experience working across markets and cultures in these roles and in his client work.

A litigator by background, in the early stages of his career Steve was an Assistant U.S. Attorney for the District of Maryland prosecuting political corruption, fraud, tax evasion, and conspiracy charges.

He then joined the firm in 1989 and built up a very successful practice dealing with complicated litigation in the health care sector. Clients have included pharmaceutical companies, medical device companies, academic health centers and medical schools, clinical laboratories, and other providers of health care. Steve has particular experience in off-label and financial relationship cases as well as the Anti-Kickback Act, the Food, Drug, and Cosmetics Act, the Foreign Corrupt Practices Act, and the False Claims Act. 

Awards and recognitions


Healthcare (District of Columbia), Eminent Practitioner
Chambers USA


Healthcare (Maryland/District of Columbia)
Chambers USA


Healthcare: Regulatory & Litigation (Nationwide)
Chambers USA


Litigation: General Commercial (Maryland/District of Columbia)
Chambers USA


Maryland Super Lawyers


Life Sciences Star
LMG Life Sciences


Criminal Defense: White Collar
The Best Lawyers in America


Bet-the-Company Litigation
The Best Lawyers in America


Commercial Litigation
The Best Lawyers in America


Business Litigation
The Best Lawyers in America


The International Who's Who of Business Crime Lawyers

Life Sciences
PLC Which Lawyer

Education and admissions


J.D., University of Maryland, Francis King Carey School of Law, cum laude, 1977

B.A., Yale University, cum laude, 1974


Member, American Health Lawyers Association

Member, Health Law Section, American Bar Association

Member, National Association of College and University Attorneys

Bar admissions and qualifications

District of Columbia


New York

Court admissions

Maryland Court of Appeals

U.S. Court of Appeals, District of Columbia Circuit

U.S. Court of Appeals, Fourth Circuit

U.S. Court of Appeals, Second Circuit

U.S. District Court, District of Columbia

Representative experience

Development of a vision and strategy for business growth for Hogan Lovells, a US$1.8bn business with operations in more than 40 offices worldwide.

Introduction of a vision for Hogan Lovells accompanied by a set of leadership behaviors designed to help everyone in the firm understand their role.

Achieved deferred prosecution, civil settlement, and corporate integrity agreements for a major orthopedic device company under investigation.

Advised medical device companies on False Claims Act matters arising from reimbursement, FDCA promotional, and fraud and abuse theories.

Advised pharmaceutical/biologics companies on federal and state investigations of sales and marketing, Medicaid rebate, and FDCA promotional issues.

Defended universities, academic health centers, and hospitals on False Claims Act disputes involving claims of billing, research, and program fraud.

Numerous assignments relating to the development of international compliance plans for corporate and institutional entities.

Successfully advised an institutional pharmacy provider with respect to Medicare Part D and related issues.

Advised medical device companies in investigations of business activities in China.

Loading data